Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Infected”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01950325
What this trial is testing

VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...

Who this might be right for
HIV-1 InfectionNeutralizing AntibodyMonoclonal Antibody+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 27
Testing effectiveness (Phase 2)Study completedNCT00299338
What this trial is testing

A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients

Who this might be right for
HIV Infections
Samaritan Pharmaceuticals, Inc 24
Testing effectiveness (Phase 2)Study completedNCT00376935
What this trial is testing

Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 99
Large-scale testing (Phase 3)Study completedNCT00098748
What this trial is testing

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects

Who this might be right for
HIV Infections
ViiV Healthcare 190
Not applicableUnknownNCT03164135
What this trial is testing

Safety of Transplantation of CRISPR CCR5 Modified CD34+ Cells in HIV-infected Subjects With Hematological Malignances

Who this might be right for
HIV-1-infection
Affiliated Hospital to Academy of Military Medical Sciences 5
Not applicableStudy completedNCT00002168
What this trial is testing

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb 200
Not applicableStudy completedNCT00312832
What this trial is testing

Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy

Who this might be right for
HIV InfectionsLipoatrophy
Hospital Clinic of Barcelona 60
Testing effectiveness (Phase 2)Study completedNCT00312091
What this trial is testing

Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 44
Testing effectiveness (Phase 2)Study completedNCT00016718
What this trial is testing

Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 43
Not applicableStudy completedNCT02257658
What this trial is testing

Efficacy of Doxycycline Prophylaxis to Reduce Syphilis in High-Risk, HIV-Positive MSM

Who this might be right for
Syphilis
Los Angeles LGBT Center 30
Not applicableStudy completedNCT01461876
What this trial is testing

Obesity in HIV After Antiretroviral Therapy

Who this might be right for
HIVAIDSObesity
Duke University 200
Not applicableStudy completedNCT00616252
What this trial is testing

Antiretroviral Drug Levels During and After Pregnancy

Who this might be right for
Pharmacokinetics
Makerere University 16
Testing effectiveness (Phase 2)Study completedNCT02415985
What this trial is testing

Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly

Who this might be right for
HIVTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 40
Post-approval studies (Phase 4)UnknownNCT00526448
What this trial is testing

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients

Who this might be right for
Chronic Hepatitis C
Hospital Carlos III, Madrid 384
Testing effectiveness (Phase 2)Active Not RecruitingNCT02494986
What this trial is testing

A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies

Who this might be right for
Human Immunodeficiency Virus Type 1
Janssen Sciences Ireland UC 48
Not applicableStudy completedNCT00142740
What this trial is testing

Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

Who this might be right for
HIV InfectionHepatitis B
University of North Carolina, Chapel Hill 337
Large-scale testing (Phase 3)Active Not RecruitingNCT02938520
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

Who this might be right for
HIV Infections
ViiV Healthcare 631
Large-scale testing (Phase 3)Study completedNCT02071082
What this trial is testing

Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults

Who this might be right for
HIVHBV
Gilead Sciences 79
Not applicableStudy completedNCT00000896
What this trial is testing

Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00903682
What this trial is testing

A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients

Who this might be right for
HIV InfectionHIVAcquired Immunodeficiency Syndrome
Janssen-Cilag International NV 157
Next Page